Hepatitis C in a French population-based survey, 1994: Seroprevalence, frequency of viremia, genotype distribution, and risk factors

Hepatology

Volumn 25, Issue 6, 1997, Pages 1490-1496

  Dubois, Frédéric ^a,b,e   Desenclos, Jean Claude ^c   Mariotte, Nicole ^a   Goudeau, Alain ^b   Drucker, J ^d   Guignard, E ^d   Buzelay, L ^b   Allemand, H ^d   Giordanella, J P ^d   Tichet, J ^a   Thevenas C ^a   Caces, E ^a   Jacquelin, J M ^a   Arondel, D ^d   Calvet, C ^d   Lemauff, J M ^d   Lepinay P ^d   Novak, M ^d   Varsat, B ^d   Rene M N ^d   Tilliet, J P ^d   Raboutet, P ^d   Leray, P ^d   Janer, P ^d   Pot, A M ^d   Fournier, B ^d   Maltesse, G ^d   Campion, J ^d   Lebrun, I ^d   Henny, J ^d   Aubry, C ^d   Deforges, D ^d   Radel, N ^d   Seyve, D ^d   Didelot, R ^d   Pignol, A M ^d   Gomez, P ^d   Estopina Gil, A M ^d   Lebas, A M ^d   more..

^a Inst Reg Pour la Sante   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

^c Hôpital National   (France)

^d Réseau Natl de S Publique ^*  (France)

^e Inst Rég Pour la S   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; FEMALE; FRANCE; GENOTYPE; HEALTH PROGRAM; HEPATITIS C; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SEROPREVALENCE; SEX DIFFERENCE; SOCIOECONOMICS; VIREMIA; VIRUS TRANSMISSION;

ADULT; ALANINE TRANSAMINASE; CASE-CONTROL STUDIES; FEMALE; FRANCE; GENOTYPE; HEALTH SURVEYS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; VIREMIA;

EID: 0030912791     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250630     Document Type: Article

References (19)

1. Van Der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994;340:1475-1479.
2. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. HEPATOLOGY 1991;14:969-974.
3. Barrera JM, Bruguera M, Ercilla MG, Gil C, Celis R, Gil MP, Del Valle Onorato M, et al. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C. HEPATOLOGY 1995;21:639-644.
4. Tong MJ, El-Ferra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-1466.
5. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, Hollinger FB, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992;327:1906-1911.
6. Verdon R, Pol S, Landais P, Mattlinger B, Carnot F, Brechot C, Busson M, et al. Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients. J Hepatol 1994;21:388-393.
7. Maisonneuve P, Couroucé AM, Ferrer Le Coeur F, Guerois C, Laurian Y, Magniez M, Parquet-Gernez, et al. Anti-VHC et receveurs: situation chez les hémophiles en 1991. Rev Fr Tranfus Hémobiol 1992;35:193-198.
8. Lucidarme D, Foutrein P, Creusy C, Forzy G, Foutrein-Comes MC, Muyssen A, Bailly D, et al. Prévalence des marqueurs des hépatites C, B et D et aspects histopathologiques dans un groupe de toxicomanes intraveineux. Gastroenterol Clin Biol 1994;18:964-968.
9. Aymard JP, Botte C, Contal P, Janot C, Streiff F. Séroprévalence des anticorps contre le virus de l'hépatite C chez les donneurs de sang. Patho Biol 1993;41:149-153.
10. Pillonel J, Couroucé AM, Laporte A, Brunet JB. Le dépistage du V.I.H, de la syphilis et des hépatites B et C dans les établissements de transfusion sanguine (E.T.S.). Bull Epidemiol Hebdo (France) 1992;39:185-187.
11. Courouce AM. Séroconversion anti-VHC chez les donneurs de sang. La Gazette de la Transfusion 1995;114:115.
12. Roudot-Thoraval F, Deforges L, Girollet JP, Maria B, Milliez J, Pathier D, Duval J, et al. Prevalence des anticorps dirigés contre le virus de l'hépatite C (tests ELISA2 et RIBA2) dans une population de femmes enceintes France. Gastroenterol Clin Biol 1992;16:255-259.
13. François M, Dubois F, Brand D, Bacq Y, Guerois C, Mouchet C, Tichet J, et al. Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations. J Clin Microbiol 1993;31:1189-1193.
14. Levy PS, Lemeshow S. Sampling of Population, Methods and Application. New York; Wiley, 1991:117-148.
15. Harnett MD. Analysis of complex sample survey data: a software review. School of Public Health Sciences, University of Massachusetts, Amherst, 1994.
16. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, et al. Epi Info, Version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Centers for Disease Control and Prevention, Atlanta, GA, 1994.
17. Schlesselman JJ. Case-Control Studies: Design, Conduct and Analysis. New York: Oxford University Press, 1982.
18. Dow BC, Coote I, Munro H. Confirmation of Hepatitis C Virus antibody in blood donors. J Med Virol 1993;41:215-220.
19. Goeser T, Müller HM, Solbach C, Gmelin K, Kurzen F, Kommerell B, Theilmann L. Prevalence and serological manifestation of hepatitis C virus infection in patients with hepatitis non-A, non-B: A follow-up study. Presse Méd 1994;23:793-796.